[Present status of therapy for viral hepatitis in Japan].
Omata
Masao
M
Department of Gastroenterology, Graduate School of Medicine, University of Tokyo.
D000998:Antiviral Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects; D007564:Japan / Q000453:epidemiology; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control; D011379:Prognosis; D012254:Ribavirin / Q000008:administration & dosage
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons